Ator-10/Ator-20/Ator-40

Ator-10/Ator-20/Ator-40

atorvastatin

Manufacturer:

InnoGen Pharmaceuticals

Distributor:

InnoGen Pharmaceuticals
Concise Prescribing Info
Contents
Atorvastatin Ca
Indications/Uses
Hyperlipidaemia [hypercholesterolemia, combined (mixed) hyperlipidaemia (type IIa or IIb hyperlipoproteinaemia), hypertriglyceridaemia (type IV) & dysbetalipoproteinaemia (type II)]. Adjunctive therapy in patients w/ homozygous familial hypercholesterolaemia who have some LDL-receptor function.
Dosage/Direction for Use
Usual initial dose: 10 mg daily. May be adjusted at intervals of 4 wk up to a max of 80 mg daily.
Administration
May be taken with or without food.
Contraindications
Active liver disease, elevated serum transaminase. Pregnancy & lactation.
Special Precautions
Not for patients w/ acute liver disease, unexplained persistently raised serum aminotransferase conc. Severe renal impairment.
Adverse Reactions
GI disturbances. Headache, skin rashes, dizziness, blurred vision, insomnia, dysguesia, nausea & vomiting, diarrhea, abdominal pain, constipation, dyspepsia & flatulence, muscle cramps, cholestatic jaundice, pruritus, hypoglycemia, hyperglycemia, anorexia, pancreatitis, alopecia, impotence, wt gain, Stevens-Johnson syndrome, back & chest pain, peripheral edema, malaise & fatigue.
Drug Interactions
Increased risk of myopathy w/ cyclosporine, fibric acid derivatives, erythromycin, niacin, or azole antifungals. Decreased plasma conc w/ oral antacid susp containing Mg & Al hydroxides, colestipol, efavirenz & rifampin. Increased steady-state plasma digoxin conc. Increased plasma conc w/ erythromycin, PIs, diltiazem HCl & grapefruit juice. Increased AUC values for norethindrone & ethinylestradiol.
ATC Classification
C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Ator-20 FC tab 20 mg
Packing/Price
30's
Form
Ator-40 FC tab 40 mg
Packing/Price
24's
Form
Ator-10 FC tab 10 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in